Searched for
CLARIS LIFE
Motilal Oswal buys 12-storey tower in Ahmedabad from Claris Life SciencesMotilal Oswal Financial Services (MOFSL) has acquired a commercial tower in Ahmedabad to support its growth and expansion plans. The proper...- Claris Life hits record high but pares most gains over regulatory concernsAnalyst who ET spoke to said the management expressed confidence that an escalation would not happen.
- Mapping the market: Bounce in dollar flattens metal stocks; Claris does a flipflopOn Friday, there was no big swing, neither was there any sign of things looking up anytime soon. And no one was talking about any Santa ral...
- Claris Life gets USFDA nod for generic anesthetic injectionThe injection is indicated for the production of local or regional anesthesia or analgesia for surgery, diagnostic and therapeutic procedur...
- BSE IT index hits record high on rupee slide, Infy, HCL Tech surgetocks of export-oriented sectors such as information technology (IT) and pharma saw a buying spree in an otherwise weak trading session.
- Claris Life surges over 10% on buzz of injectable business saleStocks of Claris Lifesciences surged over 10% today amid reports that Cadila Healthcare has emerged as the front runner to acquire the gene...
- Claris Lifesciences surges on ANDA approvalStocks of Claris Lifesciences climbed over 4% after one of its existing shareholders sold out its entire stake in the company via a block d...
- Carlyle Group sells its entire 11.29% stake in Claris LifesciencesCarlyle Group offloaded its entire 11.29 per cent stake in drug-maker Claris Lifesciences for a little over Rs 170 crore through an open ma...
- Union Budget 2015 allocation will give a boost to health care: JP NaddaThe focus, he said, within the Budget on 'Swachch Bharat' and linking this with health care has broad-based health issues in the country.
- Claris Lifesciences shares up 3.5 per cent on BSEStock of Claris Life ended the day 3.56 per cent higher at Rs 181.60 on the BSE. In intra-day, it gained 6.33 per cent to Rs 186.45.
- NPPA demands Rs 130 cr from drug makers for overcharging: Srikant Kumar Jena"A number of drug companies have been found to be selling some of their medicines to the consumers at a price higher than the ceiling price...
- Mitsui in talks to invest Rs 250 crore in ClarisSources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...
- Best Companies To Work For 2011: Claris Life Sciences provides conducive environment to retain talentThe company goes the whole hog to create affinity not only among employees but also among their family members. Special workshops for wives...
- Claris Life Sciences gets approval to market two anti-infectives injections in RussiaThe approval from Russia's Ministry of Health is to market two anti-infectives -- Fluconazole IV 100-ml and Levofloxacin IV 100-ml.
- Claris Life's IPO scrapes through, is bid 1.5 timesThe institutional category was subscribed 1.3 times, while the high-net worth individual category was subscribed 2.03 times. The retail por...
- Claris Life cuts IPO price 20%, extends closing date by 3 daysThe Rs 300-crore initial public offer of Claris Lifesciences became the first casualty of the ongoing investigation on Money Matters scam.
- Carlyle likely to dilute stake in Claris LifeTop private equity firm Carlyle Group is likely to partially exit Claris Lifesciences Ltd, the Rs 800-crore Ahmedabad based parenteral drug...
- Claris Life to tap capital marketAhmedabad-based critical care and hospital products major Claris Life Sciences is planning an initial public offering before the end of thi...
- The needle of life for Claris LifesciencesClaris Lifesciences’ niche lies in developing cheap injectibles.
- SC admits Medley Pharma's plea alleging IPR violationThe Supreme Court has admitted Medley Pharmaceuticals' plea seeking to restrain an Ahmedabad- based firm from marketing drugs under its tra...
Load More
